Results 141 to 150 of about 49,034 (223)

Preliminary exploration of radiomic mammographic analysis in triple negative breast cancer related to BRCA profile. [PDF]

Sci Rep
Pecchi A, Sessa G, Nocetti L, Beretta C, Bozzola C, Balboni E, Besutti G, Toss A, Cortesi L, Guidi G, Dominici M, Torricelli P.   +11 more
europepmc   +1 more source

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management. [PDF]

Front Oncol
Park YH, Lee SC, Singer CF, Balmaña J, Dent RA, Tan VK, Mulansari NA, Yusof MM, Que FVF, Lu YS, Parinyanitikul N, Pham CP, Taib NA, Kong SY, Antill Y, Kim HJ.   +15 more
europepmc   +1 more source

Barriers and motivators for BRCA genetic testing in Japan. [PDF]

J Genet Couns
Konnai K, Fujiwara H, Haneda E, Sato A, Saji H, Narimatsu H.   +5 more
europepmc   +1 more source

Molecular characteristics and prognostic insights into BRCA-associated breast cancer in Kazakhstan. [PDF]

Sci Rep
Samigatova A, Altaeva N, Suleimenov Y, Sibiryakov P, Zhabagin K, Zhakypbekkyzy Z, Seksenbayev B, Yoshihiro N, Tsigengagel O.   +8 more
europepmc   +1 more source

A comprehensive cancer analysis investigating the oncogenic role of zinc finger protein 36 (ZFP36) in human tumors. [PDF]

Sci Rep
Xie S, Wu H, Li X, Wang B, Liu Y, Li C, Huang Q, Yang Y, Gu S.   +8 more
europepmc   +1 more source

ISG15-driven immune modulation and tumor progression in breast cancer metastasis: insights from single-cell and spatial transcriptomics. [PDF]

BMC Med
Shao H, Tang H, Lin H, Xu Y.
europepmc   +1 more source

KIF5B-driven unfolded protein response reprograms breast cancer immunosuppressive microenvironment for single-cell guided therapeutic targeting. [PDF]

Discov Oncol
Liu Y, Li S, Luo Z, Xia Y, Zhang P.
europepmc   +1 more source

Challenges in employing overall survival as a primary outcome in ovarian cancer studies: insights from PARP inhibitor trials. [PDF]

Front Oncol
Siegler Y, Matanes E.
europepmc   +1 more source

Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India. [PDF]

J Ovarian Res
Yeshala SK, Panda SS, Moharana L, Saju SV, Rathinam K, Raju SH, Sehrawat A, Sundriyal D, Phillip AO, Kinsely PA, Bhatia KP, Kayal S, Dubashi B, Cyriac SL, Natarajan S, Samantaray L, Mohanty SS, Sadangi S, Pradhan S, Rana A, Ganesan P.   +20 more
europepmc   +1 more source

BRCA Mutation Analysis [PDF]

, 2020
openaire   +1 more source